Locally Advanced Unresectable Pancreatic Cancer: American Society of Clinical Oncology Clinical Practice Guideline Summary
- PMID: 28399382
- DOI: 10.1200/JOP.2016.017376
Locally Advanced Unresectable Pancreatic Cancer: American Society of Clinical Oncology Clinical Practice Guideline Summary
Similar articles
-
Metastatic Pancreatic Cancer: American Society of Clinical Oncology Clinical Practice Guideline Summary.J Oncol Pract. 2017 Apr;13(4):261-264. doi: 10.1200/JOP.2016.017368. Epub 2016 Oct 31. J Oncol Pract. 2017. PMID: 28399388 No abstract available.
-
Potentially Curable Pancreatic Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update Summary.J Oncol Pract. 2017 Jun;13(6):388-391. doi: 10.1200/JOP.2017.023044. Epub 2017 Apr 13. J Oncol Pract. 2017. PMID: 28406730 No abstract available.
-
Locally Advanced, Unresectable Pancreatic Cancer: American Society of Clinical Oncology Clinical Practice Guideline.J Clin Oncol. 2016 Aug 1;34(22):2654-68. doi: 10.1200/JCO.2016.67.5561. Epub 2016 May 31. J Clin Oncol. 2016. PMID: 27247216
-
Updates in locally advanced pancreatic cancer. Highlights from the "2010 ASCO Annual Meeting". Chicago, IL, USA. June 4-8, 2010.JOP. 2010 Jul 5;11(4):313-6. JOP. 2010. PMID: 20601800 Review.
-
Locally advanced pancreatic adenocarcinoma: are we making progress?. Highlights from the "2011 ASCO Annual Meeting". Chicago, IL, USA; June 3-7, 2011.JOP. 2011 Jul 8;12(4):347-50. JOP. 2011. PMID: 21737893 Review.
Cited by
-
Basics and Frontiers on Pancreatic Cancer for Radiation Oncology: Target Delineation, SBRT, SIB technique, MRgRT, Particle Therapy, Immunotherapy and Clinical Guidelines.Cancers (Basel). 2020 Jun 29;12(7):1729. doi: 10.3390/cancers12071729. Cancers (Basel). 2020. PMID: 32610592 Free PMC article. Review.
-
Application of Proteomics in Pancreatic Ductal Adenocarcinoma Biomarker Investigations: A Review.Int J Mol Sci. 2022 Feb 14;23(4):2093. doi: 10.3390/ijms23042093. Int J Mol Sci. 2022. PMID: 35216204 Free PMC article. Review.
-
Comparative efficacy and safety of neoadjuvant radiotherapy for patients with borderline resectable, and locally advanced pancreatic ductal adenocarcinoma: a systematic review and network meta-analysis protocol.BMJ Open. 2022 Jul 13;12(7):e050558. doi: 10.1136/bmjopen-2021-050558. BMJ Open. 2022. PMID: 35831044 Free PMC article.
-
Four-Tier Pathologic Tumor Regression Grading System Predicts the Clinical Outcome in Patients Who Undergo Surgical Resection for Locally Advanced Pancreatic Cancer after Neoadjuvant Chemotherapy.Gut Liver. 2022 Jan 15;16(1):129-137. doi: 10.5009/gnl20312. Gut Liver. 2022. PMID: 33875622 Free PMC article.
-
Results of a single-arm pilot study of 32P microparticles in unresectable locally advanced pancreatic adenocarcinoma with gemcitabine/nab-paclitaxel or FOLFIRINOX chemotherapy.ESMO Open. 2022 Feb;7(1):100356. doi: 10.1016/j.esmoop.2021.100356. Epub 2021 Dec 23. ESMO Open. 2022. PMID: 34953400 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical